Medullary Renal Cell Carcinoma
Also known as: Renal Medullary Carcinoma / Kidney Medullary Carcinoma / Renal medullary carcinoma (morphologic abnormality) / Renal medullary carcinoma (disorder) / Non-renal cell carcinoma of kidney / Non-renal cell carcinoma of kidney NOS
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB08875 | Cabozantinib | 1 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 1 | Active Not Recruiting | 1 |
DB01167 | Itraconazole | 1 | Completed | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB01045 | Rifampicin | 1 | Completed | 1 |
DB12887 | Tazemetostat | 1 | Completed | 1 |
DB11595 | Atezolizumab | 1 / 2 | Recruiting | 1 |
DB00091 | Cyclosporine | 1 / 2 | Completed | 1 |
DB01073 | Fludarabine | 1 / 2 | Completed | 1 |
DB00688 | Mycophenolate mofetil | 1 / 2 | Completed | 1 |
DB12887 | Tazemetostat | 1 / 2 | Enrolling by Invitation | 1 |
DB16409 | Tiragolumab | 1 / 2 | Recruiting | 1 |
DB11595 | Atezolizumab | 2 | Not Yet Recruiting | 1 |
DB08875 | Cabozantinib | 2 | Recruiting | 2 |
DB13007 | Enfortumab vedotin | 2 | Not Yet Recruiting | 1 |
DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 2 | Recruiting | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 2 |
DB06589 | Pazopanib | 2 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Not Yet Recruiting | 1 |
DB14851 | Relatlimab | 2 | Recruiting | 1 |
DB12893 | Sacituzumab govitecan | 2 | Not Yet Recruiting | 1 |
DB12887 | Tazemetostat | 2 | Completed | 1 |
DB12887 | Tazemetostat | Not Available | No Longer Available | 1 |